TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial-Reference-Cited by-同舟云学术

TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial

Published:2016-02 Issue:2 Volume:17 Page:212-223
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Quoix Elisabeth,Lena Hervé,Losonczy Gyorgy,Forget Frédéric,Chouaid Christos,Papai Zsolt,Gervais Radj,Ottensmeier Christian,Szczesna Aleksandra,Kazarnowicz Andrzej,Beck Joseph T,Westeel Virginie,Felip Enriqueta,Debieuvre Didier,Madroszyk Anne,Adam Julien,Lacoste Gisèle,Tavernaro Annette,Bastien Bérangère,Halluard Céline,Palanché Tania,Limacher Jean-Marc

Publisher

Elsevier BV

Subject

Oncology

Reference15 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;D'Addario;Ann Oncol,2010

3. 2011 focused update of 2009 American Society of Clinical Oncology clinical practice guideline update on chemotherapy for stage IV non-small-cell lung cancer;Azzoli;J Clin Oncol,2011

4. Decade in review-cancer immunotherapy: entering the mainstream of cancer treatment;Rosenberg;Nat Rev Clin Oncol,2014

5. TG4010: a therapeutic vaccine against MUC1 expressing tumors;Limacher;Oncoimmunology,2012

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The current therapeutic cancer vaccines landscape in non‐small cell lung cancer;International Journal of Cancer;2024-08-07

2. Lung cancer vaccination from concept to reality: A critical review of clinical trials and latest advances;Life Sciences;2024-06

3. Neoantigen Identification and Dendritic Cell-Based Vaccines for Lung Cancer Immunotherapy;Vaccines;2024-05-05

4. Therapeutic vaccines for advanced non-small cell lung cancer;Cochrane Database of Systematic Reviews;2024-03-12

5. Advances in cell-based delivery of oncolytic viruses as therapy for lung cancer;Molecular Therapy: Oncology;2024-03